News
6hon MSN
Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...
Mounjaro has sold more than 81,570 units in India, totalling about ₹23.94 crore ($2.76 million) as of May, with the drug ...
If you’re considering using medication to reach a healthy body weight, your first question might be: Are weight loss drugs covered by insurance? The short answer: Sometimes, but not always.
By Diana Novak Jones (Reuters) -A federal judge has rejected a bid by compounding pharmacies to allow them to continue making ...
GLP-1 medications such as Wegovy, Mounjaro and Ozempic helped drive a 9% year-over-year increase in U.S. prescription dispensing revenue, which reached $683 billion in 2024. A separate report found ...
GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.
Cancer patients should not take “quick fix” weight-loss jabs unless under specialist care, experts have warned.
Ozempic and Mounjaro's side effects have a few similar side effects as the NHS plans to rollout the jab for weight loss ...
Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery ...
Pop star Lizzo admitted that she tried Ozempic and other trendy weight loss drugs after denying accusations that she used medications to shed weight. “It’s not easy,” Lizzo confessed during a ...
Experts share recommendations for effective weight loss treatments in India, addressing the growing demand for safe and ...
1h
Zacks Investment Research on MSNLLY vs. ABBV: Which Pharma Powerhouse is the Better Bet?Eli Lilly LLY and AbbVie ABBV are U.S.-based pharmaceutical powerhouses with blockbuster drug portfolios, robust pipelines, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results